Drugmakers have failed to gain the trust of most consumers on social networking sites, a new PricewaterhouseCoopers survey has found.
The survey (n=1K U.S. consumer) suggests that 37% of consumers trust information from drug companies delivered via social media such as Facebook, with other healthcare players such as doctors (61%), hospitals (55%) and health insurers (42%) all seeming more trustworthy, according to the survey.
[AS: The definition of 'trustworthines' is opaque, and not a function of the content that pharma delivers via SM, but rather an impressionistic reflection of the the level of trust the industry enjoys (or endures) overall. My POV: there is *no* better vehicle for repairing trust in pharma over time than a fully integrated suite of properly resourced, effectively managed SM presences.]
Via Andrew Spong